Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BBI BioSeq Inc.

Latest From BBI BioSeq Inc.

FDA Collates GMP Data Integrity Advice Into Draft Guidance

A draft guidance in Q&A-format could help stave off missteps flagged in recent warning letters, more of which focus on data integrity. One basic piece of advice: data generated to satisfy a CGMP requirement is a CGMP record that must be retained.

OTC Drugs

FDA Collates GMP Data Integrity Advice Into Draft Guidance

A draft guidance in Q&A-format could help stave off missteps flagged in recent warning letters, more of which focus on data integrity. One basic piece of advice: data generated to satisfy a CGMP requirement is a CGMP record that must be retained.

OTC Drugs Cosmetics

InfraScan Inc.

InfraScan Inc. has developed a handheld device for detecting bleeding in the brain in head trauma patients. Such trauma typically causes blood from ruptured vessels to pool in the skull cavity. The trapped blood compresses the brain and increases intracranial pressure, which leads to brain damage. However by beaming near-infrared light at the brain and then analyzing the light reflected back at the device, the Infrascanner reveals the presence or non-presence of an intracranial hematoma, for triage or follow-up diagnostics.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
UsernamePublicRestriction

Register